Terns Pharmaceuticals, Inc.
TERN
$3.80
-$0.03-0.78%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 9.59% | -18.68% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.70% | 4.05% | |||
| Operating Income | -5.70% | -4.05% | |||
| Income Before Tax | -9.47% | 0.57% | |||
| Income Tax Expenses | 120.00% | -35.48% | |||
| Earnings from Continuing Operations | -9.67% | 0.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -9.67% | 0.67% | |||
| EBIT | -5.70% | -4.05% | |||
| EBITDA | -5.75% | -4.13% | |||
| EPS Basic | -9.42% | 15.28% | |||
| Normalized Basic EPS | -9.26% | 15.24% | |||
| EPS Diluted | -9.42% | 15.28% | |||
| Normalized Diluted EPS | -9.26% | 15.24% | |||
| Average Basic Shares Outstanding | 0.26% | 17.25% | |||
| Average Diluted Shares Outstanding | 0.26% | 17.25% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||